Picture of KP Tissue logo

KPT — KP Tissue News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesConservativeSmall CapTurnaround

Canada's KP Tissue Q2 revenue up on higher US sales

Canada's KP Tissue Q2 revenue up on higher US sales


Overview

  • Canada tissue products maker's Q2 revenue rose 2.8% yr/yr, slightly missing analyst expectations

  • Q2 Adjusted EBITDA grew 25% yr/yr, driven by higher U.S. sales and lower pulp prices

  • Net income for Q2 was unchanged yr/yr


Outlook

  • Company expects Q3 2026 Adjusted EBITDA to be in the range of Q2 2026

  • Company anticipates ongoing market softness in Canada due to inflationary pressure

  • Company has implemented a share recovery plan for H2 2026 to improve market share


Result Drivers

  • HIGHER U.S. SALES - Co said revenue growth was primarily due to higher sales volume in the Consumer U.S. and Away-From-Home businesses

  • LOWER PULP COSTS - Co attributed improved profitability to lower pulp prices and improved mill performance at its Memphis site

  • HIGHER SG&A EXPENSES - Co said selling, general and administrative expenses increased due to additional investment in brands, consulting, and compensation costs


Company press release: ID:nNFC508L1L


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Slight Miss*

C$550.89 mln

C$551.50 mln (3 Analysts)

Q2 EPS

C$0.24

Q2 Net Income

C$22.16 mln

Q2 Adjusted EBITDA

C$90.60 mln

Q2 Operating Income

C$59.29 mln

Q2 Pretax Profit

C$33.71 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the personal products peer group is "buy."

  • Wall Street's median 12-month price target for KP Tissue Inc is C$12.75, about 0.2% below its August 12 closing price of C$12.77

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Aug 12 - Canada's CCL Industries Q2 sales rise on CCL, Innovia segments

  • Aug 12 - Packaging firm Amcor beats quarterly sales, profit estimates on higher prices

  • Aug 11 - B&G Foods Q2 sales miss estimates on divestitures, lower base business volumes


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on KP Tissue

See all news